The global antimicrobial susceptibility testing market was valued at $3,040.00 million in 2020, and is projected to reach $4,736.03 million by 2030, registering a CAGR of 5.8% from 2021 to 2030. Antimicrobial susceptibility testing (AST) is a method for detecting which antimicrobials a certain organism or group of organisms is susceptible to. Susceptibility occurs when microorganisms such as bacteria and fungi are unable to live in the presence of one or more antimicrobial medicines. It is a laboratory approach for evaluating which antimicrobial therapy is most efficient against microorganisms. It is used to evaluate which antimicrobial prevents the growth of bacteria, fungi, and other germs that cause illness. After microorganisms that cause infection, such as bacteria, fungi, and viruses, have been isolated in a culture of the specimen, susceptibility testing is performed on them.
Antimicrobial susceptibility testing (AST) is carried out to determine the possible efficacy of various antibiotics on bacteria and/or if bacteria have evolved resistance to specific antibiotics, as well as for antifungal and antiviral species. The results of this test can be used to help choose the drug(s) most likely to be helpful in treating an illness. They are able to obtain antibiotics.
AST assists in the evaluation of treatment services provided by hospitals, clinics, and national infectious disease control and prevention programs. The testing determines a bacterium's, fungi's, or viral strain's susceptibility to a panel of antibiotics, antifungals, and antivirals. The bacterium is exposed to these antimicrobials, and the test determines whether it will grow in their presence. This information is given to physicians in the form of the Minimum Inhibitory Concentration (MIC), which is a measure of a microorganism's susceptibility or resistance to an antibiotic.
The demand for antimicrobial susceptibility testing has been on a rise due to increasing prevalence of infectious disease epidemics such as Neisseria meningitides, Shigella, Neisseria gonorrhoeae, and Salmonella serotype typhi mainly due to lack of water supply, lack of sanitation and unhygienic conditions are also boosting demand for antimicrobial susceptibility testing kits. As a result, medical practitioners have realized the need of performing antibiotic susceptibility tests (ASTs), and they are now a required component of clinical microbiology laboratories and is anticipated to drive the market
In addition, over use and misuse in consumption of antibiotics leading to antimicrobial resistances (AMR), and increased use of antimicrobial susceptibility testing by biopharmaceutical, biotechnological, and pharmaceutical companies is a major factor for the significant growth of the antimicrobial susceptibility testing market, owing to a growing emphasis on drug discovery, the emergence of new diseases, as well as the increasing incidences of chronic disorders and the rising overall population is expected to propel the market growth of mouth ulcers treatment
Furthermore, the rising prevalence of hospital acquired infections (HAIs), a rise in patient population base (particularly in developing countries), and increased government awareness to combat antimicrobial resistance are likely to drive the market even further. Testing also aids in the evaluation of treatment services provided by hospitals, clinics, and national infectious disease control and prevention programs on a larger scale. As a result of changes in microbial genes, researchers have recently required to conduct continual monitoring operations for resistance patterns.
The antimicrobial susceptibility testing market is gaining interest from healthcare businesses due to an increase in demand for automated goods such as AST cards, AST panels, and high-tech automated systems that give higher accuracy, faster processing, and improved work flow. This leads to a rise in the use of automated systems in pharmaceutical and biotechnology firms, providing a huge potential for the industry to continue growing.
In addition, opportunities in untapped, emerging markets with high potential, due to improved healthcare infrastructure, increase in unmet healthcare needs and rise in prevalence of antimicrobial resistances in populations. Availability of various manual products, automated products providing results in less time with higher accuracy for testing’s is an emerging opportunity for the key players of the market to invest in the antimicrobial susceptibility testing market and thus will further accelerate the expansion of the market offering significant growth opportunities for the market during the forecast period.
Antimicrobial Susceptibility Testing Market Segmentation
The antimicrobial susceptibility testing market is segmented onto the basis of product type, method type, end user and region. On the basis of product type, the market is categorized into manual products, automated products and consumables. By method type the market is categorized into ETEST (Epsilometer test), disks diffusion, rapid automation method and others. By end user the market is categorized into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Product Type
Manual prodcuts segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Segment review
Depending on the product type manual product segment dominated the market in 2020, and is expected to continue this trend during the forecast period, due to increase in demand for manual products due to ease of availability, simple to use and its low cost as to that of automated products.
On the basis of method type, disk diffusion segment led the market in 2020, and is expected to retain its dominance during the forecast period, owing to its popularity because of simple to use and low costs.
By end user, hospitals and diagnostic laboratories exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.
By Method
Rapid automation method segment is projected as one of the most lucrative segment.
North America accounted for a majority of the global antimicrobial susceptibility testing market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of antibiotic resistance, presence of key players, increase in healthcare expenditure, advancements in technology and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to increase in overall population, and increased investments in healthcare sector in the region.
The key players operating in the global market include Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Bruker, Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche AG, HiMedia Laboratories, Merck KGaA (MilliporeSigma), Thermo Fisher Scientific.
By Region
Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.90 % during the forecast period.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the antimicrobial susceptibility testing market, and the current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Key Market Segments
By Product Type
- Manual Products
- Consumables
- Automated Products
By Method Type
- ETEST
- Disks Diffusion
- Rapid Automation Method
- Others
By End User
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Accelerate Diagnostics, Inc.
- Becton, Dickinson and Company,
- Biomerieux SA,
- Bio-Rad Laboratories, Inc.,
- Bruker,
- Danaher Corporation (Beckman Coulter),
- F. Hoffmann-La Roche AG,
- HiMedia Laboratories,
- Merck KGaA (MilliporeSigma),
- Thermo Fisher Scientific
Antimicrobial Susceptibility Testing Market Report Highlights
| Aspects | Details |
 By PRODUCT TYPE |
|
 By METHOD TYPE |
|
 By END USER |
|
 By Region |
|
 Key Market Players | BECTON, DICKINSON, AND COMPANY, ACCELERATE DIAGNOSTICS, INC., DANAHER CORPORATION (BECKMAN COULTER INC.), MERCK KGAA (MILLIPORE SIGMA), THERMO FISHER SCIENTIFIC, INC, HIMEDIA LABORATORIES, .BRUKER CORPORATION, COMPAGNIE MERIEUX ALLIANCE SAS (BIOMERIEUX S.A.), BIO-RAD LABORATORIES, INC., .F. HOFFMANN-LA ROCHE AG |
Analyst Review
This section provides the opinions of the top level CXOs in the antimicrobial susceptibility testing market. According to the insights of CXOs, increasing prevalence of antimicrobial resistance, due to overuse and misuse of antimicrobials, rise in susceptibility testing in hospitals and clinical laboratories, are all attributed for growth of the antimicrobial susceptibility testing market.
The CXOs further added that rise in infectious diseases like tuberculosis, typhoid, cholera, pneumonia and others, surge in occurrences of epidemics and pandemics the current ongoing COVID-19 are also increasing demand for antimicrobial susceptibility testing kits. As a result, medical practitioners have recognized the significance of performing antimicrobial susceptibility tests (ASTs), and it is now an essential component of clinical microbiology laboratories.
In addition, the increasing incidence of hospital acquired infections (HAIs), surge in patient population base (especially in developing countries), rising awareness by the government to combat antimicrobial resistance is expected to further boost the market.
The antimicrobial susceptibility testing market gains interest of healthcare companies, owing to surge in demand for automated products like the AST cards, AST panels and high tech automated systems that provide higher accuracy, high speed and better work flow at the same time. This leads to increase in adoption of automated systems in pharmaceutical and biotechnological companies thus is a great opportunity for further propelling the growth of the market.
North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of infectious diseases, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in infectious diseases, rise in the number of patient population, increasing awareness in healthcare sectors. However, high cost of the automated systems and stringent government policies may restrain the market growth during the forecast period.
The total market value of antimicrobial susceptibility testing market is $3,040.0 million in 2020.
The forcast period for antimicrobial susceptibility testing market is 2021 to 2030
The market value of antimicrobial susceptibility testing market in 2021 is $2,851.52 million.
The base year is 2020 in antimicrobial susceptibility testing market
Top companies such as Accelerate Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc.,Bruker Corporation, Campaigne (Biomérieux SA), Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche AG, HiMedia Laboratories.,Merck KGaA (MilliporeSigma), Thermo Fisher Scientific Inc. held a high market position in 2020.
Manual products segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period. The manual products like susceptibility disks, plates, MIC strips used for testing are easily available, simple to use and come at an affordable cost.
Rise in incidences of various infectious diseases like tuberculosis, pnemonia, typhoid, emergence of new diseases due to gene mutations, overuse and misuse of antimicrobials leading to antimicrobial resistance (AMR) is among the key drivers propelling growth of antimicrobial susceptibility testing market globally. Furthermore, rising prevalence of testings in hospitals and diagnostics for providing appropriate therapies to patient would further push the industry growth.
North America is projected to account for a major share of the global antimicrobial susceptibility testing market during the forecast period. U.S. dominated the North America antimicrobial susceptibility testing market owing to increased infectious diseases and rise in national initiatives to combat antimicrobial resistance across the country.
Loading Table Of Content...
